false
OasisLMS
Catalog
Tele-hepatology: Evidence Based and Practical Appl ...
Tele-hepatology: Evidence Based and Practical Appl ...
Tele-hepatology: Evidence Based and Practical Applications
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The webinar on telehepatology showcased evidence-based and practical applications of telemedicine in liver care, particularly hepatitis C (HCV) and metabolic dysfunction-associated steatotic liver disease (MASLD). Dr. Andrew Talal presented a landmark randomized controlled trial integrating facilitated telemedicine within opioid treatment programs (OTPs) for HCV management in underserved populations. The telemedicine arm showed remarkably higher treatment initiation (92%) and sustained viral response (90%) compared to standard offsite referral (39% initiation, 34% SVR). The model involved onsite advanced providers facilitating telemedicine visits with specialists, with medication dispensed alongside methadone. This approach effectively overcame barriers related to geographic and temporal access, improving engagement and reducing substance use.<br /><br />Dr. Marina Serper discussed telehepatology’s role in managing MASLD, emphasizing population health approaches. She highlighted the growing prevalence of MASLD and the need for care models that combine traditional and telemedicine strategies. Telemedicine can enhance risk stratification, lifestyle interventions, pharmacotherapy, and specialist access while recognizing the necessity of in-person diagnostics (labs, imaging). Innovative models like Project ECHO for provider training, mobile units, and artificial intelligence can extend care outreach. Challenges include interstate licensure, reimbursement, digital literacy, and health equity.<br /><br />Mr. George Lyons addressed telemedicine policy, legislative dynamics, and advocacy. Current federal telehealth flexibilities were extended through September 2025 via continuing resolutions, with ongoing debates on permanent adoption due to cost concerns and fraud fears. Key bills include the CONNECT for Health Act promoting permanent telehealth expansions. Advocacy efforts focus on engaging legislators and leveraging professional societies. Proposed regulatory changes could streamline Medicare telehealth services, but uncertainties remain.<br /><br />Q&A emphasized overcoming institutional reimbursement hesitancy, interstate licensure compacts to improve access, and balancing telemedicine with necessary in-person visits, especially for cirrhosis management. Overall, telehepatology shows promise for improving liver disease care equity and outcomes.
Keywords
telehepatology
telemedicine
hepatitis C
HCV management
metabolic dysfunction-associated steatotic liver disease
MASLD
randomized controlled trial
opioid treatment programs
telehealth policy
Project ECHO
×
Please select your language
1
English